Micafungin Sodium for Injection 50 mg

Micafungin Sodium for Injection 50 mg is an antifungal medication used to treat serious fungal infections. This intravenous powder for solution is manufactured by Hikma Canada Limited and is suitable for hospital use.

Micafungin Sodium is primarily used for the treatment of invasive fungal infections, including candidiasis. It is often administered intravenously to combat fungal infections that do not respond to other treatments. Healthcare professionals may prescribe micafungin sodium for injection to manage severe fungal infections in patients who require hospitalization.

Common effects of micafungin sodium may include fever, nausea, and headache. Some patients might experience more severe reactions such as allergic responses or changes in liver function. Always consult a healthcare provider for any concerning symptoms.

Micafungin Sodium should be handled with care, ensuring proper sterile techniques during preparation and administration. Patients with known allergies to antifungal medications should inform their healthcare provider before use. Regular monitoring of liver function may be necessary during treatment.

Micafungin Sodium may interact with other medications, particularly those metabolized by the liver. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol consumption should be avoided during treatment.